The Impact of Pregnancy on Diabetic Retinopathy: A Single-Site Study of Clinical Risk Factors

• Published in: Ophthalmic research 2023, Vol.66 (1), p.1169-1180
• Main Authors: Rathinavelu, Jay, Sarvepalli, Swara M., Bailey, Beth, D'Alessio, David, Hadziahmetovic, Majda
• Format: Article
• Language: English
• Subjects: Care and treatment; Development and progression; Diabetes therapy; Diabetic retinopathy; Diabetics; Evidence-based medicine; Glycosylated hemoglobin; Health aspects; Hypertension; Medical research; Medicine, Experimental; Patient compliance; Patients; Pregnancy; Pregnant women; Research Article; Risk factors; Type 2 diabetes; Women
• ISSN: 0030-3747; 1423-0259
• DOI: 10.1159/000533416

Abstract Introduction: This study aimed to provide information on modifiable and non-modifiable risk factors for the progression and development of diabetic retinopathy (DR) and diabetic macular edema (DME). This retrospective chart review case-control study was designed to provide perspective on clinical variables. Methods: Single-center study analysis was completed with chart review, identifying 50 patients (100 eyes) ultimately included in the final analysis. Included patients were women with type 1 or 2 diabetes that entered prenatal care and had a delivery from January 2010 to December 2022. The primary outcome measure was clinical variables between progression and no progression groups. Data were analyzed via χ2 analysis and independent samples t test when appropriate. Significantly different variables were further analyzed by binary logistic regression. Results: The DR progression group had significantly higher prepregnancy HbA1c levels (9.9) when compared to the no progression group (8.5, p value 0.028). DR progression group also had higher rates (51.9%) of full-term births. The DME progression group had significantly higher rates of type 2 diabetics (100%) compared to the no progression group (30.9%, p value 0.029). Hypertension treatment before (81.8%; p value 0.008) pregnancy was also more common in the DME progression group. Intravitreal injections were more common in patients with visual acuity deterioration (26.7%, p value 0.046). The average number of fetal complications was significantly higher in the visual acuity non-worsening group (1.1) compared to the progression group (0.5, p value 0.04). These variables were not statistically significant after entry into multivariate analysis. Discussion: Severity and treatment of retinopathy before pregnancy, type of diabetes, and blood pressure control are all significant factors affecting the progression and development of severe ocular complications in pregnancy.